ResQ Biotech

Health Sciences and Wellness

ResQ Biotech is a spin-off company of the Institute of Chemical Biology of the National Hellenic Research Foundation. It was established in 2019 at the Patras Science Park. 

Its innovative platform/technology aims to discover potential medication for diseases caused by problematic protein folding and aggregation (Alzheimer’s disease, amyotrophic lateral sclerosis, cancer, systemic amyloidosis etc.). 

This biotechnological approach uses genetically engineered E. coli bacteria to biosynthesize billions of cyclic oligopeptides, an emerging class of therapeutic molecules, and simultaneously screen them to identify inhibitors of pathogenic protein misfolding and aggregation. 

ResQ Biotech aspires to become a partner of choice for every Pharma & Biotech company that is developing medication for protein misfolding diseases and looking for new assets to expand their pipelines. 

ResQ Biotech is currently raising its Seed Round of funding.